Ruth Tal-Singer

About

I am internationally recognized as an innovative, patient-focused and highly analytical healthcare leader and clinical scientist with extensive Research and Development experience. I have a proven history of successfully leading international public and private partnerships and non-profit organizations through critical advancements and progress of clinical trials and large observational cohorts. Adept at building and maintaining partnerships between Pharma, patients, academia and governments. Wide-ranging technical and scientific knowledge comprises molecular biology, immunology, application of digital technology and in vivo disease models (pre-clinical and clinical). I led the initial clinical development of GSK’s inhaled anti-muscarinic portfolio, currently available to patients as Umeclidinium bromide. Authored 160+ peer-reviewed including highly cited scientific publications (h-index 66).

Investment Focus

Location

Pennsylvania, US